NCT06100991View on ClinicalTrials.gov

CorEvitas Generalized Pustular Psoriasis (GPP) Drug Safety and Effectiveness Registry

RecruitingOBSERVATIONAL

Enrollment

200

Participants

Timeline

Start Date

September 19, 2023

Primary Completion Date

December 31, 2099

Study Completion Date

December 31, 2099

Conditions

Generalized Pustular Psoriasis

Trial Locations (1)

02451

RECRUITING

CorEvitas, LLC, Waltham

Sponsors

Lead Sponsor

All Listed Sponsors

lead

CorEvitas

NETWORK

NCT06100991 - CorEvitas Generalized Pustular Psoriasis (GPP) Drug Safety and Effectiveness Registry | Biotech Hunter | Biotech Hunter